1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid - 2-hydroxypropanoic acid (1:1)(CAS: 160738-57-8)

This compound falls under the regulatory frameworks of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations in Europe, and requirements set by the FDA and EPA in the United States. It is essential to ensure proper labeling and storage according to these guidelines to comply with safety and environmental regulations.

Alternative reagents and compounds, such as related quinoline derivatives or substituted piperazines, can be used as alternatives in the synthesis. These may offer similar or improved properties, but their effectiveness depends on the specific application and conditions of the synthesis.

Research trends indicate an increasing interest in this compound for its potential in medicinal chemistry and drug development. Market trends show a growing demand for this compound due to its unique pharmacological properties, particularly in treating certain neurological conditions. Further studies are expected to uncover new applications and enhance its therapeutic potential.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration under controlled conditions or specialized chemical recycling methods are recommended to ensure safe disposal. Environmental protection measures include proper containment to prevent spills and ensure that all waste is treated according to local regulations and guidelines.